寿仙谷：公司高度重视人工智能技术与中医药全产业链的融合应用

Core Viewpoint - The company emphasizes the integration of artificial intelligence (AI) technology with the entire traditional Chinese medicine (TCM) industry chain, aiming for intelligent upgrades and high-quality development through AI applications in various core processes [1] Group 1: AI Integration in Operations - The company has developed the world's largest Ganoderma lucidum germplasm information database, utilizing digital breeding simulations and automated phenotype data collection for precise breeding, transitioning from experimental to data-driven biological breeding [1] - AI predictive models and image recognition technologies are employed to create smart farms, enabling precise control of the growth environment for medicinal materials and intelligent quality inspection [1] - The company has independently developed a customer service Q&A robot based on customized large models, establishing an AI dynamic knowledge engine to optimize operational processes and reduce labor costs [1] Group 2: Market and Consumer Insights - AI technology is used to analyze multi-channel data, constructing user profiles based on age, physical condition, and consumption preferences, which aids in precise advertising and personalized product recommendations [1] - The company plans to continue deepening the integration of "AI + TCM" innovation, further promoting intelligent upgrades across the entire industry chain [1]